These findings suggest that further studies are required to evaluate IGF-dependent and -independent functions of Igfbp2 before choosing Igfbp2 as a therapeutic target for treatment of obesity. Here, IGFBP2 is linked to obesity due to melanocortin 4 receptor deficiency.